NCT03974815 is a NA clinical trial of ACTIVE in tDCS, sponsored by Seoul National University Hospital.

Who is sponsoring NCT03974815?

NCT03974815 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03974815?

Interventions in NCT03974815: ACTIVE, SHAM.

Is NCT03974815 still recruiting?

NCT03974815 is currently status unknown. Last updated 26 December 2019.

Last reviewed 2019-12-26 · How we verify

NCT03974815

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

tDCS(Transcranial Direct Current Stimulation) Efficacy in Bipolar Depression : RCT Study

Status unknown NA Last updated 26 December 2019

What this trial tests

NA trial testing ACTIVE in tDCS in 64 participants. Status unknown.

Timeline

25 June 2019

Primary endpoint
30 June 2020

30 October 2020

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	64
Start date	25 June 2019
Primary completion	30 June 2020
Estimated completion	30 October 2020
Sites	1 location across South Korea

Drugs / interventions tested

ACTIVE (active) — full drug profile →
SHAM

Conditions studied

tDCS — all drugs for tDCS →

Sponsor

Seoul National University Hospital

Who can join

Adults 19 to 65, any sex, with tDCS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether transcranial direct current stimulation (tDCS) is effective and safe in the treatment Bipolar depression. Randomized, double-blind Controlled Clinical Trial. Subjects Adults (between 19 and 65 years of age) with Bipolar depression who meet the inclusion criteria and who agree to participate in the study Will recruit from clinical referrals. * Active tDCS Anode - left DLPFC Cathode - right DLPFC Electric current is 2mA - Current is applied for 30 min * Sham tDCS Same assembly is used Current is applied for 1 min Both groups 30\~42 stimulation sessions on consecutive days. Baseline(visit 1), 2 week(visit 2), 4 week(visit 3), 6 week(visit 4), and 12 week(visit 5) Check compliance with mobile application(MINDD-CONNECT) connections.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy and safety of daily home-based transcranial direct current stimulation as adjunct treatment for bipolar depressive episodes: Double-blind sham-controlled randomized clinical trial.
Lee J, Lee CW, Jang Y, You JS, et al · · 2022 · cited 20× · PMID 36203828 · DOI 10.3389/fpsyt.2022.969199

Verify or expand the search:

Other trials of ACTIVE

Trials testing the same drug.

NCT06707402 — The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease · NA · recruiting
NCT06724796 — Yoga 4 Body Image (Y4BI): Investigating the Impact of Yoga on Body Image and Eating Behaviours · NA · recruiting
NCT04195165 — The Effect of Sitting and Moderate Exercise on Plasma Insulin and Glucose Responses to an Oral Glucose Tolerance Test · NA · unknown

Other recruiting trials for tDCS

Currently open trials in the same condition.

NCT07400939 — Brain Stimulation Combined With Watching Hand Movements to Improve Hand Recovery in Chronic Stroke · NA · recruiting
NCT07246044 — HD-tDCS for Adolescent Bipolar Depression Targeting S1 · NA · recruiting
NCT06986278 — tdCS Combined With Treadmill Training in Patients With Multiple Sclerosis · NA · recruiting
NCT07073287 — Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients · Phase 2 · recruiting
NCT06212609 — Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies · NA · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03974815 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 26 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03974815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing